A recent study from Australian and Dutch experts revealed that older patients with kidney tumours who are not candidates for surgery may benefit from targeted, high-dose radiation.
The new device, the size and shape of a grain of rice, can run dozens of trials at once to evaluate the impact of novel medicines on some of the most difficult-to-treat brain malignancies.
A recent study from the University of Michigan Department of Neurosurgery and Rogel Cancer Centre demonstrates encouraging preliminary findings that a therapy combining cell-killing and immune-stimulating drugs is safe and effective in extending survival for patients with gliomas, a particu
A study performed by UCLA Jonsson Comprehensive Cancer Centre researchers gave new light on why tumours that have spread to the brain from other parts of the body react to immunotherapy whereas glioblastoma, an aggressive brain cancer, does not.
According to recent research published in the Journal of Experimental Medicine, equipping cancer-infecting viruses with tumor-inhibiting genetic cargo boosts the immune system and supports immunotherapy in reducing or totally eradicating aggressive tumours in mice. The findings pave the path
According to a new study published in the Journal of Experimental Medicine, equipping cancer-infecting viruses with tumour-inhibiting genetic cargo promotes the immune system and aids immunotherapy in shrinking or completely clearing aggressive tumours in mice. The findings pave the way f
Glioblastoma, the most prevalent and lethal type of brain cancer, spreads quickly, invading and destroying healthy brain tissue. The tumour shoots malignant tendrils into the brain, making surgical removal of the tumour extremely difficult or impossible.
Researchers have discovered a protein that is crucial to the operation of numerous novel cancer medicines. The discovery, according to the researchers, will probably help with efforts to optimize the use of immunotherapies against a number of difficult tumors.
Hyderabad (Telangana) [India], July 18: The goal of the collaboration is to reduce the time and resources it takes to translate a biomedical breakthrough into a clinically and commercially viable medicine.
Research headed by Nagoya University in Japan discovered three previously unknown membrane proteins in ovarian cancer. The scientists captured the proteins using a novel technique comprised of nanowires with a polyketone coating, providing a new detection tool for ovarian cancer.
Ultrasound is a potential cancer treatment tool. Unlike laser light, which is employed in photodynamic cancer therapy, ultrasonic waves may penetrate deep into tissue (up to 12 cm) to treat deep tumours while causing no harm to healthy cells.